Efamed/Efamed Plus Indications/Uses

Efamed tablet/syrup: For the relief of bronchospasm in bronchial asthma, chronic bronchitis, emphysema, and other reversible obstructive pulmonary disease.
Efamed solution for nebulization: Indicated for use in the routine management of chronic bronchospasm unresponsive to conventional therapy and in the treatment of acute severe asthma. Salbutamol is a direct acting sympathomimetic with mainly beta adrenergic activity and a selective action on beta 2 (a beta 2 agonist). This results in its bronchodilating action being more prominent than its effect on the heart. Salbutamol and salbutamol sulfate are used as bronchodilators in the management of reversible airways obstruction, as in the asthma and in some patients with chronic obstructive pulmonary disease. Salbutamol also decreases uterine contractility and may be given as the sulfate to arrest premature labour. Inhalation results in the rapid onset (within 5 minutes) of bronchodilation, which lasts about 3-6 hours. After oral doses, the onset of action is within 30 minutes, with a peak effect between 2-3 hours after dose, and a duration of action of up to 6 hours; modified release preparations that have a longer duration of action are available. Salbutamol is used as the base or sulfate in aerosol inhalers and as the sulfate in other preparations. The dosage is expressed in terms of salbutamol base; salbutamol sulfate 1.2mg is equivalent to about 1mg of salbutamol.
Efamed Plus tablet/syrup: Treatment or prevention of bronchospasm. Relief of respiratory obstruction & improves pulmonary ventilation. Respiratory disorders complicated by bronchospasm & excessive secretion of tenacious mucus eg bronchial asthma, chronic bronchitis & emphysema.